eli lilly tirzepatide compound launches lower-price weight-loss drug without injector pen Impurity in Some Compounded Tirzepatide

This is strongly linked to metabolic disorders, including Type 2 diabetes (T2D), hypertension, cardiovascular disease, and nonalcoholic fatty liver disease (MASH)

Even if you feel well, do not stop this medicine on your own because high blood pressure often has no symptoms

Volpe S, Lisco G, Racaniello D, Fanelli M, Colaianni V, Vozza A, et al

I have always thought, along with other colleagues for a long time, that you can start identifying groups that have lived with obesity for a very long period of time and they would somehow present differently metabolically and so on, and it would give us an understanding of what treatments would be better for someone, let's say, with long-term obesity versus someone with short-term obesity

M., & Ascher, D